Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Future of NZ's clinical research under microscope


Future of New Zealand's clinical research under the microscope

GlaxoSmithKline is launching what it hopes will only be the start of annual clinical research forums in New Zealand.

The inaugural National Clinical Trials Seminar is being held on Saturday 1 November at the Heritage Hotel, Hobson Street, Auckland, from 9am to 4pm.

Topics will include the trans-Tasman agreement, the role of DHBs in clinical research, Maori consultation, ethics committees, indemnity and compensation.

"The symposium is open to anybody with an interest in clinical research including clinicians, research nurses, general nurses and the pharmaceutical industry," GlaxoSmithKline medical director Dr Ian Griffiths says.

The idea for a New Zealand clinical research forum came from GSK's clinical research team. The team attended the Australian Clinical Research Symposium last year and found the experience extremely valuable. It also sparked the idea to hold a similar event here celebrating New Zealand research.

GlaxoSmithKline invests the equivalent of NZ $8 billion annually in clinical research around the world and in addition to being involved with the international research GSK New Zealand has also invested $8 million in clinical research right here. This research includes asthma, looking at the effects of the company's latest type 2 diabetes medication on cardiovascular disease in type 2 diabetes patients, research looking at combination treatment for chronic obstructive pulmonary disease (COPD) and studies looking at the prevention of prostate cancer and treatment of atrial fibrillation.

It is for this reason the clinical research team believes an annual symposium will provide a valuable and exciting platform for New Zealand's clinical researchers to come together, Dr Griffiths says. "The company believes this is an important enough initiative to take a lead and organise the first event. However, it is hoped others will take on the organisation of future forums, and that the forums will become an annual event."

The deadline for registration is the end of September. Registration forms can be accessed on the GlaxoSmithKline website www.gsk-conferences.co.nz

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>

ALSO:

Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>

ALSO:

I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>

ALSO:

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news